Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
37.64
-0.74 (-1.93%)
At close: Dec 10, 2025, 4:00 PM EST
37.75
+0.11 (0.29%)
After-hours: Dec 10, 2025, 6:16 PM EST
Vericel Revenue
Vericel had revenue of $67.50M in the quarter ending September 30, 2025, with 16.58% growth. This brings the company's revenue in the last twelve months to $258.72M, up 14.05% year-over-year. In the year 2024, Vericel had annual revenue of $237.22M with 20.10% growth.
Revenue (ttm)
$258.72M
Revenue Growth
+14.05%
P/S Ratio
7.28
Revenue / Employee
$724,697
Employees
357
Market Cap
1.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 237.22M | 39.71M | 20.10% |
| Dec 31, 2023 | 197.52M | 33.15M | 20.17% |
| Dec 31, 2022 | 164.37M | 8.18M | 5.24% |
| Dec 31, 2021 | 156.18M | 32.01M | 25.77% |
| Dec 31, 2020 | 124.18M | 6.33M | 5.37% |
| Dec 31, 2019 | 117.85M | 26.99M | 29.71% |
| Dec 31, 2018 | 90.86M | 26.93M | 42.13% |
| Dec 31, 2017 | 63.92M | 9.54M | 17.54% |
| Dec 31, 2016 | 54.38M | 3.22M | 6.28% |
| Dec 31, 2015 | 51.17M | 22.37M | 77.69% |
| Dec 31, 2014 | 28.80M | 28.78M | 151,457.89% |
| Dec 31, 2013 | 19.00K | -2.00K | -9.52% |
| Dec 31, 2012 | 21.00K | 3.00K | 16.67% |
| Dec 31, 2011 | 18.00K | -71.00K | -79.78% |
| Jun 30, 2010 | 89.00K | -93.00K | -51.10% |
| Jun 30, 2009 | 182.00K | -340.00K | -65.13% |
| Jun 30, 2008 | 522.00K | -163.00K | -23.80% |
| Jun 30, 2007 | 685.00K | -178.00K | -20.63% |
| Jun 30, 2006 | 863.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
VCEL News
- 26 days ago - Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025 - GlobeNewsWire
- 4 weeks ago - Vericel Corporation (VCEL) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings - The Motley Fool
- 4 weeks ago - Vericel Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025 - GlobeNewsWire
- 4 months ago - Vericel Q2 Revenue Jumps 20% - The Motley Fool
- 4 months ago - Vericel Corporation (VCEL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Vericel Reports Second Quarter 2025 Financial Results - GlobeNewsWire